{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:31:17Z","timestamp":1791156677894,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/cad.0000000000000051","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T16:03:21Z","timestamp":1386086601000},"page":"495-501","source":"Crossref","is-referenced-by-count":16,"title":["Clinical features of taxane neuropathy"],"prefix":"10.1097","volume":"25","author":[{"given":"David","family":"Kudlowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Muggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1158\/1078-0432.CCR-13-0572","article-title":"Defining risks of taxane neuropathy: insights from randomized clinical trials.","volume":"19","author":"Kudlowitz","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/cncr.11578","article-title":"Measuring the side effects of taxane therapy in oncology.","volume":"98","author":"Cella","year":"2003","journal-title":"Cancer"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.47.1.115","article-title":"Motor neuropathy due to docetaxel and paclitaxel.","volume":"47","author":"Freilich","year":"1996","journal-title":"Neurology"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ijgc-00009577-200311000-00002","article-title":"Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5.","volume":"13","author":"Bookman","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/1097-0142(20010215)91:4<664::AID-CNCR1049>3.0.CO;2-P","article-title":"Phase I study of vinorelbine and paclitaxel by 3-h simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma.","volume":"91","author":"Ibrahim","year":"2001","journal-title":"Cancer"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1081\/CNV-120000363","article-title":"Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.","volume":"20","author":"Ibrahim","year":"2002","journal-title":"Cancer Invest"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jnci\/89.1.87","article-title":"Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations.","volume":"89","author":"Budman","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2009.233","article-title":"Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel.","volume":"87","author":"Koolen","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1025412509730","article-title":"Effect of valspodar on the pharmacokinetics of unbound paclitaxel.","volume":"21","author":"Ten Tije","year":"2003","journal-title":"Invest New Drugs"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:BREA.0000021046.29834.12","article-title":"Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure.","volume":"85","author":"Guo","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1200\/JCO.2005.16.006","article-title":"Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer.","volume":"23","author":"Aghajanian","year":"2005","journal-title":"J Clin Oncol"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4049\/jimmunol.162.1.467","article-title":"Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin synthase-2 isozyme.","volume":"162","author":"Moos","year":"1999","journal-title":"J Immunol"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.95.7.3896","article-title":"Taxane-mediated gene induction is independent of microtubule stabilization: Induction of transcription regulators and enzymes that modulate inflammation and apoptosis.","volume":"95","author":"Moos","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.","volume":"7","author":"Synold","year":"2001","journal-title":"Nat Med"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T17:02:54Z","timestamp":1688835774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201406000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000051","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}